Request Free Sample ×

Kindly complete the form below to receive a free sample of this Report

* Please use a valid business email

Leading companies partner with us for data-driven Insights

clients tt-cursor
Hero Background

US Prebiotic Ingredients Market

ID: MRFR/FnB/14810-HCR
128 Pages
Snehal Singh
Last Updated: April 06, 2026

US Prebiotic Ingredients Market Size, Share, Industry Trend & Analysis Research Report: By Type (Oligosaccharides, Inulin, Polydextrose, Others), By Source (Roots, Grains, Vegetables), By Functions (Gut, Bone, Immunity, Heart, Weight Management) andBy Applications (Bakery and Confectionery, Dairy and Frozen Desserts, Dietary Supplements, Sweet and Savory Snacks, Oil And Fats, Beverages, Others)- Forecast to 2035

Share:
Download PDF ×

We do not share your information with anyone. However, we may send you emails based on your report interest from time to time. You may contact us at any time to opt-out.

US Prebiotic Ingredients Market Infographic
Purchase Options
  1. 1 SECTION I: EXECUTIVE SUMMARY AND KEY HIGHLIGHTS
  2.   1.1 EXECUTIVE SUMMARY
  3.     1.1.1 Market Overview
  4.     1.1.2 Key Findings
  5.     1.1.3 Market Segmentation
  6.     1.1.4 Competitive Landscape
  7.     1.1.5 Challenges and Opportunities
  8.     1.1.6 Future Outlook
  9. 2 SECTION II: SCOPING, METHODOLOGY AND MARKET STRUCTURE
  10.   2.1 MARKET INTRODUCTION
  11.     2.1.1 Definition
  12.     2.1.2 Scope of the study
  13.       2.1.2.1 Research Objective
  14.       2.1.2.2 Assumption
  15.       2.1.2.3 Limitations
  16.   2.2 RESEARCH METHODOLOGY
  17.     2.2.1 Overview
  18.     2.2.2 Data Mining
  19.     2.2.3 Secondary Research
  20.     2.2.4 Primary Research
  21.       2.2.4.1 Primary Interviews and Information Gathering Process
  22.       2.2.4.2 Breakdown of Primary Respondents
  23.     2.2.5 Forecasting Model
  24.     2.2.6 Market Size Estimation
  25.       2.2.6.1 Bottom-Up Approach
  26.       2.2.6.2 Top-Down Approach
  27.     2.2.7 Data Triangulation
  28.     2.2.8 Validation
  29. 3 SECTION III: QUALITATIVE ANALYSIS
  30.   3.1 MARKET DYNAMICS
  31.     3.1.1 Overview
  32.     3.1.2 Drivers
  33.     3.1.3 Restraints
  34.     3.1.4 Opportunities
  35.   3.2 MARKET FACTOR ANALYSIS
  36.     3.2.1 Value chain Analysis
  37.     3.2.2 Porter's Five Forces Analysis
  38.       3.2.2.1 Bargaining Power of Suppliers
  39.       3.2.2.2 Bargaining Power of Buyers
  40.       3.2.2.3 Threat of New Entrants
  41.       3.2.2.4 Threat of Substitutes
  42.       3.2.2.5 Intensity of Rivalry
  43.     3.2.3 COVID-19 Impact Analysis
  44.       3.2.3.1 Market Impact Analysis
  45.       3.2.3.2 Regional Impact
  46.       3.2.3.3 Opportunity and Threat Analysis
  47. 4 SECTION IV: QUANTITATIVE ANALYSIS
  48.   4.1 Life Sciences, BY Type (USD Million)
  49.     4.1.1 Oligosaccharides
  50.     4.1.2 Inulin
  51.     4.1.3 Polydextrose
  52.     4.1.4 Others
  53.   4.2 Life Sciences, BY Source (USD Million)
  54.     4.2.1 Roots
  55.     4.2.2 Grains
  56.     4.2.3 Vegetables
  57.   4.3 Life Sciences, BY Function (USD Million)
  58.     4.3.1 Gut
  59.     4.3.2 Bone
  60.     4.3.3 Immunity
  61.     4.3.4 Heart
  62.     4.3.5 Weight Management
  63.   4.4 Life Sciences, BY Application (USD Million)
  64.     4.4.1 Bakery and Confectionery
  65.     4.4.2 Dairy and Frozen Desserts
  66.     4.4.3 Dietary Supplements
  67.     4.4.4 Sweet and Savory Snacks
  68.     4.4.5 Oil and Fats
  69.     4.4.6 Beverages
  70.     4.4.7 Others
  71. 5 SECTION V: COMPETITIVE ANALYSIS
  72.   5.1 Competitive Landscape
  73.     5.1.1 Overview
  74.     5.1.2 Competitive Analysis
  75.     5.1.3 Market share Analysis
  76.     5.1.4 Major Growth Strategy in the Life Sciences
  77.     5.1.5 Competitive Benchmarking
  78.     5.1.6 Leading Players in Terms of Number of Developments in the Life Sciences
  79.     5.1.7 Key developments and growth strategies
  80.       5.1.7.1 New Product Launch/Service Deployment
  81.       5.1.7.2 Merger & Acquisitions
  82.       5.1.7.3 Joint Ventures
  83.     5.1.8 Major Players Financial Matrix
  84.       5.1.8.1 Sales and Operating Income
  85.       5.1.8.2 Major Players R&D Expenditure. 2023
  86.   5.2 Company Profiles
  87.     5.2.1 Beneo (BE)
  88.       5.2.1.1 Financial Overview
  89.       5.2.1.2 Products Offered
  90.       5.2.1.3 Key Developments
  91.       5.2.1.4 SWOT Analysis
  92.       5.2.1.5 Key Strategies
  93.     5.2.2 DuPont (US)
  94.       5.2.2.1 Financial Overview
  95.       5.2.2.2 Products Offered
  96.       5.2.2.3 Key Developments
  97.       5.2.2.4 SWOT Analysis
  98.       5.2.2.5 Key Strategies
  99.     5.2.3 Ingredion (US)
  100.       5.2.3.1 Financial Overview
  101.       5.2.3.2 Products Offered
  102.       5.2.3.3 Key Developments
  103.       5.2.3.4 SWOT Analysis
  104.       5.2.3.5 Key Strategies
  105.     5.2.4 Tate & Lyle (GB)
  106.       5.2.4.1 Financial Overview
  107.       5.2.4.2 Products Offered
  108.       5.2.4.3 Key Developments
  109.       5.2.4.4 SWOT Analysis
  110.       5.2.4.5 Key Strategies
  111.     5.2.5 FrieslandCampina (NL)
  112.       5.2.5.1 Financial Overview
  113.       5.2.5.2 Products Offered
  114.       5.2.5.3 Key Developments
  115.       5.2.5.4 SWOT Analysis
  116.       5.2.5.5 Key Strategies
  117.     5.2.6 Kerry Group (IE)
  118.       5.2.6.1 Financial Overview
  119.       5.2.6.2 Products Offered
  120.       5.2.6.3 Key Developments
  121.       5.2.6.4 SWOT Analysis
  122.       5.2.6.5 Key Strategies
  123.     5.2.7 Nutraceutical International (US)
  124.       5.2.7.1 Financial Overview
  125.       5.2.7.2 Products Offered
  126.       5.2.7.3 Key Developments
  127.       5.2.7.4 SWOT Analysis
  128.       5.2.7.5 Key Strategies
  129.     5.2.8 ProbioFerm (DE)
  130.       5.2.8.1 Financial Overview
  131.       5.2.8.2 Products Offered
  132.       5.2.8.3 Key Developments
  133.       5.2.8.4 SWOT Analysis
  134.       5.2.8.5 Key Strategies
  135.     5.2.9 Sensus (NL)
  136.       5.2.9.1 Financial Overview
  137.       5.2.9.2 Products Offered
  138.       5.2.9.3 Key Developments
  139.       5.2.9.4 SWOT Analysis
  140.       5.2.9.5 Key Strategies
  141.   5.3 Appendix
  142.     5.3.1 References
  143.     5.3.2 Related Reports
  144. 6 LIST OF FIGURES
  145.   6.1 MARKET SYNOPSIS
  146.   6.2 US MARKET ANALYSIS BY TYPE
  147.   6.3 US MARKET ANALYSIS BY SOURCE
  148.   6.4 US MARKET ANALYSIS BY FUNCTION
  149.   6.5 US MARKET ANALYSIS BY APPLICATION
  150.   6.6 KEY BUYING CRITERIA OF LIFE SCIENCES
  151.   6.7 RESEARCH PROCESS OF MRFR
  152.   6.8 DRO ANALYSIS OF LIFE SCIENCES
  153.   6.9 DRIVERS IMPACT ANALYSIS: LIFE SCIENCES
  154.   6.10 RESTRAINTS IMPACT ANALYSIS: LIFE SCIENCES
  155.   6.11 SUPPLY / VALUE CHAIN: LIFE SCIENCES
  156.   6.12 LIFE SCIENCES, BY TYPE, 2024 (% SHARE)
  157.   6.13 LIFE SCIENCES, BY TYPE, 2024 TO 2035 (USD Million)
  158.   6.14 LIFE SCIENCES, BY SOURCE, 2024 (% SHARE)
  159.   6.15 LIFE SCIENCES, BY SOURCE, 2024 TO 2035 (USD Million)
  160.   6.16 LIFE SCIENCES, BY FUNCTION, 2024 (% SHARE)
  161.   6.17 LIFE SCIENCES, BY FUNCTION, 2024 TO 2035 (USD Million)
  162.   6.18 LIFE SCIENCES, BY APPLICATION, 2024 (% SHARE)
  163.   6.19 LIFE SCIENCES, BY APPLICATION, 2024 TO 2035 (USD Million)
  164.   6.20 BENCHMARKING OF MAJOR COMPETITORS
  165. 7 LIST OF TABLES
  166.   7.1 LIST OF ASSUMPTIONS
  167.     7.1.1
  168.   7.2 US MARKET SIZE ESTIMATES; FORECAST
  169.     7.2.1 BY TYPE, 2025-2035 (USD Million)
  170.     7.2.2 BY SOURCE, 2025-2035 (USD Million)
  171.     7.2.3 BY FUNCTION, 2025-2035 (USD Million)
  172.     7.2.4 BY APPLICATION, 2025-2035 (USD Million)
  173.   7.3 PRODUCT LAUNCH/PRODUCT DEVELOPMENT/APPROVAL
  174.     7.3.1
  175.   7.4 ACQUISITION/PARTNERSHIP
  176.     7.4.1

US Life Sciences Market Segmentation

Life Sciences By Type (USD Million, 2025-2035)

  • Oligosaccharides
  • Inulin
  • Polydextrose
  • Others

Life Sciences By Source (USD Million, 2025-2035)

  • Roots
  • Grains
  • Vegetables

Life Sciences By Function (USD Million, 2025-2035)

  • Gut
  • Bone
  • Immunity
  • Heart
  • Weight Management

Life Sciences By Application (USD Million, 2025-2035)

  • Bakery and Confectionery
  • Dairy and Frozen Desserts
  • Dietary Supplements
  • Sweet and Savory Snacks
  • Oil and Fats
  • Beverages
  • Others

Compare Licence

×
Features License Type
Single User Multiuser License Enterprise User
Price $4,950 $5,950 $7,250
Maximum User Access Limit 1 User Upto 10 Users Unrestricted Access Throughout the Organization
Free Customization
Direct Access to Analyst
Deliverable Format
Platform Access
Discount on Next Purchase 10% 15% 15%
Printable Versions